Our specialization in the sector translates in multi-country studies, covering global life science markets from the USA, Europe, Asia, LATAM and even Africa. And we love to share all those gained insights: after all, we consider transparency towards our customers one of our highest values.
In 2020, we presented our insights on R&D Strategy in Diagnostic Blood & Plasma Screening Technology during an EphMRA webinar. Click the button below to
This research will discuss how to research competitive customer experience and how to use the difference customer experience value drivers to make the relative positioning of your brand.
COVID-19 has had a significant impact on surgical procedure volumes, especially on elective procedures. The MedTech industry expects a rebound in Q3 and Q4. However,
Introduction Robot assisted surgery, having evolved from a niche research area in the late 1980’s, now represents one of the fastest growing divisions in the
Introduction Medical device manufacturers must increase their efforts towards the hospital economic customers in order to successfully launch products and maintain profitability. Increased cost
The impact of COVID-19 on the diagnostics field: Laboratory Test Volumes, Challenges and Potential Services to Improve Workflow
Introduction Laboratory testing has a central position in providing insight and direction on the evolution of the COVID-19 pandemic. Laboratories are requested to increase testing
Introduction Major medical device manufacturers indicated their procedure volumes decreased by -80% during Q1 of 2020. In their Q1 earnings reports, they highlighted the cancellation